Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00114114 · ClinicalTrials.gov registry record · NA

Dose-Response of Gonadal Steroids and Bone Turnover in Older Men

A NA study of Healthy Volunteers, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
177
Enrollment target
1
Study location

NCT00114114 is a NA study of Healthy Volunteers that has completed, run by Massachusetts General Hospital. The registered enrollment target is 177 participants, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00114114, a NA study of Healthy Volunteers, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
177 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur in older men. This information may help determine when to intervene with hormone replacement therapy in aging men.

Conditions Studied

Interventions

  • DRUG Testosterone
  • DRUG Goserelin acetate

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 177 participants
Start Date 2004-09
Est. Completion 2017-11-01
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT00114114

The ClinicalTrials.gov registry entry for NCT00114114 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (63% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 2 interventions - of which Testosterone is the first listed.

NCT00114114 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00114114 about?

NCT00114114 is a clinical study titled "Dose-Response of Gonadal Steroids and Bone Turnover in Older Men". The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur in older men. This information may help determine when to intervene with hormone replacement therapy in aging men.

What is the current status of trial NCT00114114?

This trial is currently completed. It is a NA study. The enrollment target is 177 participants. The study started on 2004-09. Estimated completion is 2017-11-01.

What conditions does trial NCT00114114 study?

This clinical trial studies the following conditions: Healthy Volunteers.

What interventions are being tested in trial NCT00114114?

The interventions under investigation include: Testosterone (DRUG), Goserelin acetate (DRUG).

Who is sponsoring clinical trial NCT00114114?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00114114 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.